snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers (Review)
Jiahui Mao, Hao Lin, Feng Gu, Zhaoji Pan · 2026
Read snoRNAs and their derived sdRNAs: Emerging regulators, biomarkers, and therapeutic targets in human cancers (Review) by Jiahui Mao, Hao Lin, Feng Gu, Zhaoji Pan (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13238223.txt.
Description
Jiahui Mao, Hao Lin, Feng Gu, and Zhaoji Pan review small RNA strands and cancer in a 2026 paper. These strands normally guide chemical marks on the cell's protein-making machinery. New sequencing work shows they go off balance in many diseases, above all in cancer.
The review covers how the strands form, how they are classed, and what they do beyond their classic job. They can shape gene splicing, message stability, and protein contacts. In tumors they sway growth, spread, metabolism, and drug resistance. The authors map their changes across major cancers, including colon, liver, stomach, lung, breast, and ovarian types. The strands may serve as markers or drug targets.
Catalog record
| CREATOR | Jiahui Mao, Hao Lin, Feng Gu, Zhaoji Pan |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 75 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |